Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Central Dogma01:20

The Central Dogma

31.4K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
31.4K
The Central Dogma01:25

The Central Dogma

138.3K
Overview
138.3K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

8.9K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
8.9K
What is Genetic Engineering?00:49

What is Genetic Engineering?

79.3K
Overview
79.3K
From DNA to Protein03:06

From DNA to Protein

21.5K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
21.5K
Gene Therapy00:59

Gene Therapy

27.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Throughput Profiling of Prenylelongases Enables the Assembly of Modified Prenoids.

ACS chemical biology·2026
Same author

Engineering Fluoroacetate Dehalogenase by Growth-Based Selections on Non-Natural Organofluorides.

Angewandte Chemie (International ed. in English)·2026
Same author

Sialic Acid-Containing Glycolipids Extend the Receptor Repertoire of Enterovirus-D68.

ACS infectious diseases·2025
Same author

A Robust Growth-Based Selection Platform to Evolve an Enzyme via Dependency on Noncanonical Tyrosine Analogues.

JACS Au·2024
Same author

Tethered Ribosomes: Toward the Synthesis of Nonproteinogenic Polymers in Bacteria.

Chembiochem : a European journal of chemical biology·2023
Same author

SARS-CoV-2 Spike N-Terminal Domain Engages 9-<i>O</i>-Acetylated α2-8-Linked Sialic Acids.

ACS chemical biology·2023
Same journal

Sustainable Synthesis of Bio-Based Furanic and Aromatic Amines Using an Optimized Whole-Cell Transaminase-Decarboxylase Cascade in E. coli RARE.

Chembiochem : a European journal of chemical biology·2026
Same journal

Composite Dissolvable Microneedle-Enabled Local High-Dose Delivery of Endogenous Thiols for Efficient Allergic Dermatitis Treatment.

Chembiochem : a European journal of chemical biology·2026
Same journal

Revisiting the Radical Quenching Activity of Ebselen Analogues in Homogeneous Phase and In Silico Anti-ferroptotic Activity with Histone Deacetylase.

Chembiochem : a European journal of chemical biology·2026
Same journal

Reaction Optimization for Enzymatic Deconstruction of Industrially Relevant Nylon Composites.

Chembiochem : a European journal of chemical biology·2026
Same journal

Deploying Artificial Metalloenzymes in Complex Environments: Strategies and Applications.

Chembiochem : a European journal of chemical biology·2026
Same journal

Synthetic Ligands of Myeloid C-Type Lectin Receptors.

Chembiochem : a European journal of chemical biology·2026
See all related articles

Related Experiment Video

Updated: Dec 16, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.0K

Genetic-Code-Expansion Strategies for Vaccine Development.

Jelle A Fok1, Clemens Mayer1

  • 1Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 4, 9474 AG, Groningen (The, Netherlands.

Chembiochem : a European Journal of Chemical Biology
|July 2, 2020
PubMed
Summary
This summary is machine-generated.

Genetic code expansion offers novel vaccine development strategies. Incorporating noncanonical amino acids enhances immune responses and enables new vaccine designs for prophylactic and therapeutic applications.

Keywords:
genetic code expansionimmunochemistryprotein modificationsvaccine developmentvirus attenuation

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.3K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.7K

Related Experiment Videos

Last Updated: Dec 16, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.0K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.3K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.7K

Area of Science:

  • Biotechnology
  • Immunology
  • Vaccinology

Background:

  • Vaccines have drastically reduced infectious disease mortality globally.
  • 21st-century biotechnological progress enables advanced vaccine development.
  • Vaccines are increasingly explored as therapeutics for human diseases.

Purpose of the Study:

  • To review the application of genetic code expansion in vaccine development.
  • To highlight the potential of noncanonical amino acids in vaccine design.
  • To discuss future prospects and challenges in this field.

Main Methods:

  • Review of literature on genetic code expansion techniques.
  • Analysis of methods for incorporating noncanonical amino acids.
  • Exploration of applications in prophylactic and therapeutic vaccines.

Main Results:

  • Genetic code expansion allows the incorporation of immunogenic noncanonical amino acids.
  • This approach can enhance immune responses against self-proteins.
  • Expanded genetic codes can facilitate the creation of replication-incompetent viral vaccines.

Conclusions:

  • Genetic code expansion is a promising emerging tool for vaccine development.
  • Further research is needed to overcome challenges for clinical application.
  • This technology holds potential for both prophylactic and therapeutic vaccines.